Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer

針對症狀 Lung Cancer
臨床試驗編號 NCT00103116
臨床階段 Phase II
臨床試驗位址 Markey Cancer Center
目前研究進度 This study has been completed.
試驗開始日期 February 8, 2005
試驗開始日期 April 4, 2017
臨床目的

RATIONALE: Vaccines made from a person's white blood cells and allogeneic tumor cells may make the body build an effective immune response to kill tumor cells.

PURPOSE: This phase II trial is studying how well vaccine therapy works in treating patients with stage I, stage II, or stage III non-small cell lung cancer.

https://clinicaltrials.gov/ct2/show/NCT00103116?term=DC&recrs=e&cond=lung+cancer&draw=2&rank=4

登入

登入成功